Hardy Diagnostics Partners with ProGnosis Biotech to Distribute Advanced Environmental Monitoring Solutions in the U.S.

Hardy Diagnostics, a leading provider of laboratory testing products, is proud to announce its partnership with ProGnosis Biotech, a Greece-based company specializing in the development of advanced immunoassays for food safety diagnostics and hygiene monitoring. As part of this partnership, Hardy will become the first U.S. distributor for ProGnosis Biotech's innovative Allergen-Free series of lateral flow test kits. The Allergen-Free Test product line consists of rapid test kits for the detection of 17 major food allergens. These quantitative lateral flow tests deliver results in just 5 minutes, making them ideal for quick and accurate allergen detection in various production environments. Featuring a unified workflow, users have the option to perform multiple allergen tests from a single prepared sample. The tests utilize a common green extraction buffer and boast extreme sensitivity with a very low limit of detection, ensuring reliable results. To achieve standardized interpretation of results and full traceability, these lateral flow tests can be paired with the ProGnosis Biotech 3PR-Mini Lateral Flow reader, which delivers quantitative results from surface, liquid, and solid samples. Find more information on Prognosis Biotech Allergen-Free testing solutions, click here. This collaboration underscores Hardy Diagnostics’ dedication to providing comprehensive testing solutions for food safety professionals. In addition to hygiene verification and allergen testing products from ProGnosis, Hardy also offers microbial environmental monitoring solutions with Labplas sample collection tools, CompactDry sample-ready dehydrated media plates, and much more.